Epicore Biosystems

Epicore Biosystems

Private
Cambridge, MassachusettsFrontier & Industrial Techhttps://epicorebiosystems.com

Last Round

Grant

Jul 23, 2025

Est. Valuation

$84.5M

Total Funding Raised

$133.05M

Momentum Score

25 /100

Company Overview

Epicore Biosystems is a digital health company that develops advanced sweat-sensing wearables that provide real-time personalized hydration and health insights.

Sector

Frontier & Industrial Tech

Verticals

Health IoT, Sports Analytics, Medical Devices, Sensors, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

sweat sensorhydration monitoringwearable patchindustrial athlete monitoringheat stress monitoringbiosensorconnected worker platformwearable sensorhealth analyticsnon-invasive monitoringsports performancemicrofluidic sensorelectrolyte monitoringhealth IoTworkplace safetydigital healthclinical research tools

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epicore Biosystems Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Epicore Biosystems Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 23, 2025
Series BMay 14, 2025
Series BFeb 10, 2025
Series BFeb 10, 2025
Series BDec 11, 2024
Series A Extension
Jan 17, 2024

Key People

Founding team and executive leadership

Stephen Lee

Chief Technical Officer, Co-Founder

Founding Team

John Wright

Chief Operating Officer, SVP Translational Research Development

Executive Team

Epicore Biosystems Investors

Notable investors and investment history

InvestorRounds
Global Brain CorporationSeries B
Fenox Venture CapitalSeries B
Joyance PartnersSeries B, Series A
Chevron Technology VenturesSeries A
Alumni VenturesSeries B, Series A
Steele Foundation for HopeSeries B
Pegasus Tech VenturesSeries B, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Added Hivesystems, a cybersecurity SMB, as a customer.

  • Jan 22, 2026

    Added Rayonier Advanced Materials, a Chemicals/Manufacturing company.

Epicore Biosystems Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epicore Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epicore Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range39
Year Founded2017
Last FundingJul 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.